BRIEF published on 11/14/2024 at 07:03, 9 days 2 hours ago Grenke AG Reaffirms Preliminary Financial Figures for 2024 Financial Results 2024 Outlook GRENKE AG Insolvencies Lease Growth
PRESS RELEASE published on 11/14/2024 at 06:58, 9 days 2 hours ago grenke reaffirms preliminary figures grenke AG reaffirms preliminary figures for Q3 and Q1-Q3 2024, with group earnings at EUR 57.0 million. Continued growth in lease receivables and outlook for 2024 explained Preliminary Figures GRENKE AG Q3 2024 Group Earnings Lease Receivables
BRIEF published on 11/05/2024 at 16:03, 17 days 17 hours ago GRENKE Leads SDAX in Corporate Governance Rating Corporate Governance Financial Analysis GRENKE AG SDAX DVFA Scorecard
PRESS RELEASE published on 11/05/2024 at 15:58, 17 days 17 hours ago Top marks for grenke Corporate Governance grenke AG achieves top marks in corporate governance, ranking 1st in the SDAX with 83.14% DVFA Scorecard 2024. First 'very good' rating among SDAX companies Corporate Governance Financial Analysis GRENKE AG SDAX DVFA Scorecard
BRIEF published on 10/30/2024 at 00:01, 24 days 9 hours ago Grenke Reports Preliminary Third Quarter 2024 Figures Financial Forecast Leasing Market Net Interest Income Risk Provisioning Grenke Earnings
PRESS RELEASE published on 10/29/2024 at 23:56, 24 days 9 hours ago grenke publishes preliminary figures for the third quarter of 2024 grenke AG publishes preliminary figures for Q3 2024, reporting a rise in net interest income but a decline in Group earnings, caused by higher expenses for claims and risk provisioning Preliminary Figures GRENKE AG Q3 2024 Net Interest Income Group Earnings
BRIEF published on 10/29/2024 at 23:28, 24 days 9 hours ago GRENKE Adjusts Group Earnings Forecast Amid Rising Insolvencies Financial Forecast GRENKE AG Earnings Guidance Risk Provisioning Insolvency Rates
PRESS RELEASE published on 10/29/2024 at 23:23, 24 days 9 hours ago EQS-Adhoc: grenke reduces Group earnings guidance grenke AG reduces Group earnings guidance for 2024 financial year due to higher expenses for settlement of claims and risk provisioning GRENKE AG Earnings Guidance 2024 Financial Year Risk Provisioning Expenses
BRIEF published on 10/02/2024 at 07:04, 1 month 21 days ago Grenke AG Achieves Strong New Business in Q3 2024 GRENKE AG Q3 2024 CM2 Margin Regional Growth Leasing New Business
PRESS RELEASE published on 10/02/2024 at 06:59, 1 month 21 days ago grenke achieves strong new business in Q3 2024 grenke AG reports strong new business growth in Q3 2024, with leasing up by 24.9% to EUR 738.5 million. CM2 grows by 29.1%, reaching EUR 125.8 million. CEO and CFO comments indicate positive outlook Leasing GRENKE AG Q3 2024 New Business CM2
Published on 11/22/2024 at 23:55, 9 hours 21 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 46 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 11 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 46 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 23 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 21 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 16 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
